13804 W.107th St.,
JRH, headquartered in Lenexa, Kansas, has major manufacturing facilities and/or serum collection and processing centers in Caseyville, Illinois, Lenexa, Kansas, and Denver, Pennsylvania in the United States; Andover in the United Kingdom; and Brisbane and Brooklyn in Australia. JRH's product lines include sera, cell culture media used in the production of therapeutic proteins, reagent growth factors and biological material containers. JRH has approximately 400 employees.
JRH Biosciences was acquired by Sigma-Aldrich on February 28, 2005.
Join Mergr to view all 75 acquisitions of life science companies in 2005, including 16 acquisitions by private equity firms, and 59 by strategics.
Out of 60 sectors in the Mergr database, life science ranked 14 in number of deals in 2005. The largest life science acquisition in 2005 was Ivax - which was acquired by Teva Pharmaceutical Industries for $7.4B.
Join Mergr to view this profile - and discover more life science acquisitions of companies like JRH Biosciences.
No obligation. Cancel anytime.